GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Interest Income

Solvonis Therapeutics (LSE:SVNS) Interest Income : £0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Solvonis Therapeutics Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Solvonis Therapeutics's interest income for the six months ended in Jun. 2024 was £0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in Jun. 2024 was £0.00 Mil.

Solvonis Therapeutics Interest Income Historical Data

The historical data trend for Solvonis Therapeutics's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solvonis Therapeutics Interest Income Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23
Interest Income
Get a 7-Day Free Trial - - - - -

Solvonis Therapeutics Semi-Annual Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Solvonis Therapeutics Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solvonis Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Interest Income
Comparable Companies
LSE:EQT LSE:SNT LSE:XSG XTER:SIE XPAR:SU ETN PH OSTO:ATCO A ITW EMR CMI XTER:ENR TSE:7011 AME OTIS IR ROK XSWX:SCHN XYL OHEL:KNEBV
Traded in Other Exchanges
J4I:Germany
Address
Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Website
https://www.solvonis.com
Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Solvonis Therapeutics Headlines

No Headlines